| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 30,571,000 | 31,076,000 | 31,342,000 | 30,866,000 | | Cost of Revenue | 12,242,000 | 12,923,000 | 13,070,000 | 12,127,000 | | | Gross Profit | 18,329,000 | 18,153,000 | 18,272,000 | 18,739,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 7,706,000 | 8,211,000 | 7,676,000 | 7,214,000 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 4,886,000 | 5,044,000 | 4,978,000 | 4,958,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 5,737,000 | 4,898,000 | 5,618,000 | 6,567,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (15,000) | (498,000) | (81,000) | (43,000) | | Earnings Before Interest And Taxes | 5,859,000 | 4,507,000 | 5,794,000 | 6,736,000 | | Interest Expense | 849,000 | 813,000 | 858,000 | 854,000 | | Income Before Tax | 5,010,000 | 3,694,000 | 4,936,000 | 5,882,000 | | Income Tax Expense | 1,809,000 | 1,290,000 | 1,706,000 | 2,110,000 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 3,201,000 | 2,404,000 | 3,230,000 | 3,772,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 3,201,000 | 2,404,000 | 3,230,000 | 3,772,000 | | Preferred Stock And Other Adjustments | (75,000) |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $3,126,000 | $2,404,000 | $3,230,000 | $3,772,000 |
|
3.07% Nasdaq 
Income Statement
